Sigachi Industries Limited · NSE:SIGACHI
Sigachi Industries — Q1 FY2025 Earnings Presentation
29 slides from Sigachi Industries's earnings presentation, Aug 6, 2024
Slide 1: Cover letter to stock exchanges for Investor Presentation Q1 FY 2024-25
SIGACHI INDUSTRIES LIMITED CIN: L24110TG1989PLC009497 AN EXCiPACT GMP, ISO 9001:2015 &FSSC 22000 CERTIFIED COMPANY To, Date: 06-08-2024 The Manager The Manager, BSE Limited National Stock Exchange of India Limited, P. J. Towers, Dalal Street Exchange Plaza, Bandra Kurla Complex, Mumbai-400001 Bandra
Slide 2: Sigachi Industries Ltd Investor Presentation – Q1FY25
SIGACHI INDUSTRIES LTD Investor Presentation – Q1FY25
Slide 3: Agenda
Agenda Operational & Financial 01 Company Overview 03 Highlights 02 Strategic Positioning 04 Annexure 2
Slide 4: Message from MD & CEO
At Sigachi, we're not just about delivering products; we're about delivering excellence. Our enduring partnerships with industry giants stand as monuments to the unparalleled quality we consistently provide. Our sights are set on becoming an undisputed powerhouse across the entire pharmaceutical eco
Slide 5: Company Overview
SIGACHI INDUSTRIES LTD Company Overview
Slide 6: Top Global Manufacturer of Pre-Formulated Excipient
Top 5 Global Manufacturer of Pre-Formulated Excipient 5 Cutting Edge 21,000 MTPA Capacity 3 Decades of 60+ Widely Used Manufacturing Facilities 3 Strategic Locations Expertise excipients including expansion at Dahej and Jhagadia. 337+ Customers 5 Years Revenue 5 Years EBITDA 5 Years PAT Across 65 Co
Slide 7: Business Overview
Business Overview Total Revenue Break up (%) (Q1FY25) Allied Trades 5% API 9% Operations and Management 11% 75% MCC 6
Slide 8: Sigachi's De-Risked Business Model
Sigachi’s De-Risked Business Model Leading Trusted Name Present in the Cutting -edge Manufacturer of Across All entire Pharma Manufacturing MCC in India Operational Ecosystem Capabilities Business Segments 7
Slide 9: Strategic Positioning
SIGACHI INDUSTRIES LTD Strategic Positioning
Slide 10: Present Across the Pharma Ecosystem
Present Across the Pharma Ecosystem Moving Up the Value chain by Introducing Value Added and Margin Accretive Products in the Product Basket MCC API CCS Core Business Vertical Expanded Product Offering Complementary to Existing Business o Largest Manufacturer in India o Acquired 80% stake in Trimax
Slide 11: One of the Largest Manufacturer of MCC in the World
One of the Largest Manufacturer of MCC in the World Maximizing Capacity: Efficient Utilization (Q1 FY 25) The capacity (7,200 MTPA) added in Q4FY24 resulted in an increase to total capacity of 21,000 MTPA 85.39% o Leading MCC Manufacturer in India 55.90% 53.25% o Operating at a combined capacity of
Slide 12: Core Business More than Doubled in 5 Years
Core Business More than Doubled in 5 Years MCC Revenue Grew 2.6x Revenue (Rs. Mn) MCC Revenue CAGR : 21% (FY19-FY24) 14,740 12,655 12,793 11,446 9,159 8,876 3,015 2,603 2,266 1,773 1,173 1,265 FY19 FY20 FY21 FY22 FY23 FY24 Revenue (Rs. Mn) Volume (MTPA) 11
Slide 13: Robust Growth in O&M Business
Robust Growth in O&M Business Revenue Tripled O&M Revenue (Rs. Mn) Trusted Partners o Gujarat Alkalies o Aditya Birla Group o ONGC Petro Additions o Lords Chloro Alkali Limited o Adani Enterprises Limited 351 265 Asset Light Model 90 110 122 134 o Zero Capex Requirement o Contracts Win to Boost FY19
Slide 14: Research & Product Excellence
Research & Product Excellence Quality Assurance through Cutting-edge Facilities, Expert R&D, Accreditation, and Certification Hyderabad Plant Jhagadia Plant Dahej SEZ Plant R&D Division Manufacturing Units Expansion Plans o Three units in Hyderabad, Telangana (Unit I), Jhagadia, Gujarat o Expanding
Slide 15: Achieving 3x Growth in Revenue and PAT
Achieving 3x Growth in Revenue and PAT Revenue (Rs. Mn) EBITDA (Rs. Mn) PATPAT (Rs. Mn) 16.0% 21.2% 15.7% 20.1% 20.1% 19.4% 14.7% 19.2% 14.6% 14.4% 14.3% 4,106 3,087 17.8% 766.5 400.4 435.4 2,529 530.4 587.3 1,960 302.6 387.9 572.0 1,439 190.1 203.2 1,329 259.6 247.6 FY19 FY20 FY21 FY22 FY23 FY24 FY
Slide 16: Sustainable Margins
Sustainable Margins Sustainable Margins Returns to Stake holders 21.2% 20.1% 20.1% 52.1% 19.4% 19.2% 17.8% 20% 37.4% 19% 19% 18.9% 34.1% 42.4% 17% 31.5% 32.1% 22.2% 16% 19.7% 15.7% 16.0% 16.41% 14.7% 14.6% 14.4% 14.34% 17.6% 16.2% 13.64% FY19 FY20 FY21 FY22 FY23 FY24 FY19 FY20 FY21 FY22 FY23 FY24 EB
Slide 17: Low Debt: Maximizing Financial Stability
Low Debt: Maximizing Financial Stability Gross Block (Rs.Mn) Net Debt to Equity and Interest Coverage Ratio 45.31 31.04 2,157 0.46 0.28 13.68 1,151 0.03 0.13 682.5 0.02 416.5 503.3 366.1 FY19 FY20 FY21 FY22 FY23 FY24 FY19 FY20 FY21 FY22 FY23 FY24 10.56 7.52 9.82 -0.15 Net Debt to Equity Interest Cov
Slide 18: Cash Flows
Cash Flows To Drive Future Growth Cash Flows from Operation (Rs.Mn) Capex (Rs Mn) 1,007 296 290 852 145 121 129 243 59 93 FY19 FY20 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 17
Slide 19: Operational and Financial Highlights Q1FY25
SIGACHI INDUSTRIES LTD Operational and Financial Highlights Q1FY25
Slide 20: Q1FY25 Operational Highlights
Q1FY25 Operational Highlights • The overall income for the year ended experienced a YoY growth of 13%, increasing from INR 863.3 Million to INR 973.8 Million. • The quantity of MCC demonstrated a YoY growth of 1.62%, increasing from 3,448 MT to 3,504 MT in Q1FY 25 compared to Q1 FY24. • Revenues fro
Slide 21: Q1FY25 Financial Highlights
Q1FY25 Financial Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) & EBITDA Margin % PAT (Rs. Mn) & PAT Margin % 19.4% 21.9% 12.9% 13.38% 957 210 128 164 109 847 Q1FY24 Q1FY25 Q1FY24 Q1FY25 Q1FY24 Q1FY25 15.65% 21.9% 14.60% 13.38% 1,041 210 152 163 957 128 Q4FY24 Q1FY25 Q4FY24 Q1FY25 Q4FY2
Slide 22: Income Statement
Income Statement Q1FY25 Particulars (Rs. Mn) Q1FY25 Q1FY24 YoY Q4FY24 QoQ Revenue from Operations 957 847 13.00% 1,041 (8.07)% Total Expenses 747 683 9.37% 878 (14.92)% EBITDA 210 164 28.05% 163 28.83% EBITDA Margin 21.94% 19.36% 258 Bps 15.65% 629 Bps Depreciation and Amortization 31 20 - 35 - Fina
Slide 23: Annexure
SIGACHI INDUSTRIES LTD Annexure
Slide 24: Historical Income Statement
Historical Income Statement Particulars (Rs. Mn) FY21 FY22 FY23 FY24 Revenue from Operations 1,928 2,503 3,020 3,989 Total Expenses 1,540 1,972 2,433 3,223 EBITDA 388 531 587 766 EBITDA Margin 20.12% 21.21% 19.43% 19.20% Depreciation and Amortisation 23 29 66 108 Finance costs 13 12 43 78 Other Inco
Slide 25: Historical Balance Sheet
Historical Balance Sheet Particulars (Rs. Mn) FY21 FY22 FY23 FY24 NON-CURRENT ASSETS 463 1,069 1,964 3,809 a) Property, plant and equipment 376 527 960 1,711 b) Capital work-in-progress 37 97 349 966 c) Intangible assets 3 7 7 14 d) Goodwill - - - 547 e) Right of Use Assets - - 257 277 f) Financial
Slide 26: Historical Balance Sheet
Historical Balance Sheet Particulars (Rs. Mn) FY21 FY22 FY23 FY24 EQUITY 942 2,277 2,683 4,410 Equity Share Capital 77 307 307 328 Other Equity 865 1,970 2,376 3,968 Equity attributable to the owners of the company 942 2,277 2,683 4,296 Minority Interest - - - 114 NON-CURRENT LIABILITIES 70 76 308 6
Slide 27: Key Milestones
Key Milestones 2009:Setting up of 100 % export oriented unit (“EOU”) for manufacturing MCC in the SEZ at Dahej, Gujarat. 1998:Commenced its export operations 2014 :Merger of Sigachi 2023:Acquired Trimax by exporting its Cellulose Private Limited and Sigachi Biosciences Pvt Ltd to expand product Plas
Slide 28: Strong Leadership
Strong Leadership Mr. R P Sinha Mr. Chidambarnathan Mr. Amit Raj Sinha Mr. O Subbarami Reddy Founder, Chairperson, Shanmuganathan MD & CEO Chief Financial Officer Whole-Time Director Co-Founder, Whole-Time Director o Holds PG Diploma in business o He has an MBA from Indian o He is a qualified Charte
Slide 29: Thank You
Go India Advisors – IR Firm Ms. Priya Sen Ms. Deepika Sharma Ms. Sheetal Khanduja priya@goindiaadvisors.com deepika@goindiaadvisors.com sheetal@goindiaadvisors.com M : +91 8334841047 M:+91 8451029510 M: +91 9769364166 Thank You